Literature DB >> 23731971

The E5 proteins.

Daniel DiMaio1, Lisa M Petti.   

Abstract

The E5 proteins are short transmembrane proteins encoded by many animal and human papillomaviruses. These proteins display transforming activity in cultured cells and animals, and they presumably also play a role in the productive virus life cycle. The E5 proteins are thought to act by modulating the activity of cellular proteins. Here, we describe the biological activities of the best-studied E5 proteins and discuss the evidence implicating specific protein targets and pathways in mediating these activities. The primary target of the 44-amino acid BPV1 E5 protein is the PDGF β receptor, whereas the EGF receptor appears to be an important target of the 83-amino acid HPV16 E5 protein. Both E5 proteins also bind to the vacuolar ATPase and affect MHC class I expression and cell-cell communication. Continued studies of the E5 proteins will elucidate important aspects of transmembrane protein-protein interactions, cellular signal transduction, cell biology, virus replication, and tumorigenesis.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; EGF receptor; HPV; PDGF receptor; Papillomaviruses; Transmembrane proteins; Vacuolar ATPase

Mesh:

Substances:

Year:  2013        PMID: 23731971      PMCID: PMC3772959          DOI: 10.1016/j.virol.2013.05.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  180 in total

1.  The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.

Authors:  Barbara Marchetti; G Hossein Ashrafi; Emmanouella Tsirimonaki; Philippa M O'Brien; M Saveria Campo
Journal:  Oncogene       Date:  2002-11-07       Impact factor: 9.867

2.  Towards a structural understanding of the smallest known oncoprotein: investigation of the bovine papillomavirus E5 protein using solution-state NMR.

Authors:  Gavin King; Joanne Oates; Dharmesh Patel; Hugo A van den Berg; Ann M Dixon
Journal:  Biochim Biophys Acta       Date:  2010-11-10

3.  Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor.

Authors:  Kristina Talbert-Slagle; Sara Marlatt; Francisco N Barrera; Ekta Khurana; Joanne Oates; Mark Gerstein; Donald M Engelman; Ann M Dixon; Daniel Dimaio
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

4.  Connexin 43 expression is downregulated in raft cultures of human keratinocytes expressing the human papillomavirus type 16 E5 protein.

Authors:  P Tomakidi; H Cheng; A Kohl; G Komposch; A Alonso
Journal:  Cell Tissue Res       Date:  2000-08       Impact factor: 5.249

5.  Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein.

Authors:  G Joan Grindlay; M Saveria Campo; Vincent O'Brien
Journal:  Virus Res       Date:  2005-03       Impact factor: 3.303

6.  Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells.

Authors:  Jung-Min Oh; Su-Hyeong Kim; Eun-Ah Cho; Yong-Sang Song; Woo-Ho Kim; Yong-Sung Juhnn
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

7.  Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle.

Authors:  Sante Roperto; Roberta De Tullio; Cinzia Raso; Roberto Stifanese; Valeria Russo; Marco Gaspari; Giuseppe Borzacchiello; Monica Averna; Orlando Paciello; Gianni Cuda; Franco Roperto
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

8.  The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells.

Authors:  G F Valle; L Banks
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

9.  The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.

Authors:  M Conrad; D Goldstein; T Andresson; R Schlegel
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

10.  Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?

Authors:  Annunziata Corteggio; Gennaro Altamura; Franco Roperto; Giuseppe Borzacchiello
Journal:  Infect Agent Cancer       Date:  2013-01-09       Impact factor: 2.965

View more
  82 in total

Review 1.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Two transmembrane dimers of the bovine papillomavirus E5 oncoprotein clamp the PDGF β receptor in an active dimeric conformation.

Authors:  Alexander G Karabadzhak; Lisa M Petti; Francisco N Barrera; Anne P B Edwards; Andrés Moya-Rodríguez; Yury S Polikanov; J Alfredo Freites; Douglas J Tobias; Donald M Engelman; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 3.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

Review 4.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

5.  Characterization of HPV and host genome interactions in primary head and neck cancers.

Authors:  Michael Parfenov; Chandra Sekhar Pedamallu; Nils Gehlenborg; Samuel S Freeman; Ludmila Danilova; Christopher A Bristow; Semin Lee; Angela G Hadjipanayis; Elena V Ivanova; Matthew D Wilkerson; Alexei Protopopov; Lixing Yang; Sahil Seth; Xingzhi Song; Jiabin Tang; Xiaojia Ren; Jianhua Zhang; Angeliki Pantazi; Netty Santoso; Andrew W Xu; Harshad Mahadeshwar; David A Wheeler; Robert I Haddad; Joonil Jung; Akinyemi I Ojesina; Natalia Issaeva; Wendell G Yarbrough; D Neil Hayes; Jennifer R Grandis; Adel K El-Naggar; Matthew Meyerson; Peter J Park; Lynda Chin; J G Seidman; Peter S Hammerman; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

6.  Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.

Authors:  Gaurav Raikhy; Brittany L Woodby; Matthew L Scott; Grace Shin; Julia E Myers; Rona S Scott; Jason M Bodily
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

Review 7.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

Review 8.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

9.  HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Authors:  Sayuri Miyauchi; P Dominick Sanders; Kripa Guram; Sangwoo S Kim; Francesca Paolini; Aldo Venuti; Ezra E W Cohen; J Silvio Gutkind; Joseph A Califano; Andrew B Sharabi
Journal:  Cancer Res       Date:  2019-12-17       Impact factor: 12.701

10.  Structure of Full-Length Human PDGFRβ Bound to Its Activating Ligand PDGF-B as Determined by Negative-Stain Electron Microscopy.

Authors:  Po-Han Chen; Vinzenz Unger; Xiaolin He
Journal:  J Mol Biol       Date:  2015-10-20       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.